Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine citrate maintenance dose comparison for extubation success in premature infants
IRCT20230408057850N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of caffeine in apnea of prematurity (AOP) (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Tracheal extubation failure and Post-extubation apnea. Started Apr 2023; status: completed.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on IRCT20230408057850N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230408057850N1.